Cihat Aytekin
Research Subjects
Cihat Aytekin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ali Atan
Department of Urology, Gazi University School of Medicine, Ankara, Turkey
2 shared publications - Ender Cem Bulut
Department of Urology, School of Medicine, Gazi University, Ankara, Turkey
2 shared publications - Fazlı Polat
School of Medicine, Department of Urology, Gazi University, Emniyet Mh., Yenimahalle/Ankara, Turkey
2 shared publications - Mahmut Uğurlu
Department of Urology, Mardin Training and Research Hospital, Mardin, Turkey.
2 shared publications - Süleyman Yeşil
School of Medicine, Department of Urology, Gazi University, Emniyet Mh., Yenimahalle/Ankara, Turkey
2 shared publications - Ali Unsal
School of Medicine, Department of Urology, Gazi University, Emniyet Mh., Yenimahalle/Ankara, Turkey
1 shared publication
Latest Publications
- 18 May 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Risk factors and the impact of comorbidities in patients developing urethral stricture after transurethral resection of the prostate
Urethral stricture remains a clinically relevant complication after transurethral resection of the prostate (TURP). While procedural factors have been extensively studied, the contribution of systemic comorbidities to stricture development is less well defined. This study aimed to evaluate the association between common cardiovascular and metabolic comorbidities and urethral stricture formation following TURP. A retrospective cohort of 713 patients who underwent bipolar TURP for benign prostatic hyperplasia between January 2021 and January 2024 was analyzed. Urethral stricture was identified in 47 patients (6.6%). Propensity score matching (1:4) was performed based on age, prostate volume, operative time, and PSA levels, yielding a matched cohort of 235 patients. Comorbidities including smoking, hypertension, diabetes mellitus, dyslipidemia, and coronary artery disease (CAD) were assessed using clinical records and prescription data. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify factors associated with time to urethral stricture development. In the matched cohort, smoking, hypertension, CAD, and dyslipidemia were significantly more prevalent in patients who developed urethral stricture (all p < 0.05), whereas diabetes mellitus was not. In univariable Cox analysis, smoking (HR 2.13), hypertension (HR 2.76), CAD (HR 3.15), and dyslipidemia (HR 2.46) were significantly associated with an increased hazard of urethral stricture development. In multivariable Cox analysis, only CAD remained independently associated with the outcome (HR 2.06, 95% CI 1.02-4.16, p = 0.04). The most common stricture location was the bulbar urethra. Coronary artery disease was independently associated with urethral stricture development following TURP. Other comorbidities may contribute through overlapping vascular and metabolic pathways. These findings highlight the importance of systemic disease burden when assessing postoperative stricture risk and planning perioperative management.
- 18 May 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Risk factors and the impact of comorbidities in patients developing urethral stricture after transurethral resection of the prostate
Urethral stricture remains a clinically relevant complication after transurethral resection of the prostate (TURP). While procedural factors have been extensively studied, the contribution of systemic comorbidities to stricture development is less well defined. This study aimed to evaluate the association between common cardiovascular and metabolic comorbidities and urethral stricture formation following TURP. A retrospective cohort of 713 patients who underwent bipolar TURP for benign prostatic hyperplasia between January 2021 and January 2024 was analyzed. Urethral stricture was identified in 47 patients (6.6%). Propensity score matching (1:4) was performed based on age, prostate volume, operative time, and PSA levels, yielding a matched cohort of 235 patients. Comorbidities including smoking, hypertension, diabetes mellitus, dyslipidemia, and coronary artery disease (CAD) were assessed using clinical records and prescription data. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify factors associated with time to urethral stricture development. In the matched cohort, smoking, hypertension, CAD, and dyslipidemia were significantly more prevalent in patients who developed urethral stricture (all p < 0.05), whereas diabetes mellitus was not. In univariable Cox analysis, smoking (HR 2.13), hypertension (HR 2.76), CAD (HR 3.15), and dyslipidemia (HR 2.46) were significantly associated with an increased hazard of urethral stricture development. In multivariable Cox analysis, only CAD remained independently associated with the outcome (HR 2.06, 95% CI 1.02-4.16, p = 0.04). The most common stricture location was the bulbar urethra. Coronary artery disease was independently associated with urethral stricture development following TURP. Other comorbidities may contribute through overlapping vascular and metabolic pathways. These findings highlight the importance of systemic disease burden when assessing postoperative stricture risk and planning perioperative management.
- 6 August 2025
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 17 (5) , e70027
Does Metabolic Syndrome Influence Surgical Success? Outcomes of Transurethral Resection of Prostate and Open Prostatectomy in Large‐Volume Benign Prostate Hyperplasia
Objective: This study aimed to compare the perioperative outcomes of open prostatectomy (OP) and transurethral resection of the prostate (TURP) in patients with large‐volume benign prostatic hyperplasia (BPH) and to evaluate the impact of metabolic syndrome (MetS) on surgical outcomes.Materials and Methods: In this retrospective study, 239 patients with a prostate volume greater than 80 cc who underwent TURP (n = 122) or OP (n = 117) between 2018 and 2024 were included. MetS was diagnosed according to NCEP‐ATP III 2005 criteria. Postoperative IPSS, Qmax, PVR, hemoglobin levels, and complication rates were compared between groups and by MetS status.Results: Both groups demonstrated significant improvements in IPSS and Qmax postoperatively (p < 0.001). MetS did not significantly impact postoperative IPSS, Qmax, or PVR in either group (p > 0.05). MetS components such as HDL, triglycerides, and waist circumference showed no meaningful correlation with surgical outcomes.Discussion: In patients with large prostate volumes, both surgical techniques yielded significant symptomatic improvement; while metabolic syndrome did not significantly influence postoperative IPSS, Qmax, or PVR outcomes.
- 6 August 2025
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 17 (5) , e70027
Does Metabolic Syndrome Influence Surgical Success? Outcomes of Transurethral Resection of Prostate and Open Prostatectomy in Large‐Volume Benign Prostate Hyperplasia
Objective: This study aimed to compare the perioperative outcomes of open prostatectomy (OP) and transurethral resection of the prostate (TURP) in patients with large‐volume benign prostatic hyperplasia (BPH) and to evaluate the impact of metabolic syndrome (MetS) on surgical outcomes.Materials and Methods: In this retrospective study, 239 patients with a prostate volume greater than 80 cc who underwent TURP (n = 122) or OP (n = 117) between 2018 and 2024 were included. MetS was diagnosed according to NCEP‐ATP III 2005 criteria. Postoperative IPSS, Qmax, PVR, hemoglobin levels, and complication rates were compared between groups and by MetS status.Results: Both groups demonstrated significant improvements in IPSS and Qmax postoperatively (p < 0.001). MetS did not significantly impact postoperative IPSS, Qmax, or PVR in either group (p > 0.05). MetS components such as HDL, triglycerides, and waist circumference showed no meaningful correlation with surgical outcomes.Discussion: In patients with large prostate volumes, both surgical techniques yielded significant symptomatic improvement; while metabolic syndrome did not significantly influence postoperative IPSS, Qmax, or PVR outcomes.